Drug
Vivotif Typhoid Oral Vaccine
Vivotif Typhoid Oral Vaccine is a pharmaceutical drug with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph phase_4
3
75%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting2
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (25.0%)
Phase 43 (75.0%)
Trials by Status
recruiting250%
active_not_recruiting250%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_4
Blood Donor CVD 5000
NCT03971669
active_not_recruitingphase_4
CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults
NCT03970304
active_not_recruitingearly_phase_1
Induction of Gut Permeability by an Oral Vaccine
NCT04083950
recruitingphase_4
CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
NCT03705585
Clinical Trials (4)
Showing 4 of 4 trials
NCT03971669Phase 4
Blood Donor CVD 5000
NCT03970304Phase 4
CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults
NCT04083950Early Phase 1
Induction of Gut Permeability by an Oral Vaccine
NCT03705585Phase 4
CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4